Nanocare Technologies, Inc. (New York) was co-founded in 2010 by Dr. Milo Lopes (San Carlos, Brazil) and David Katona (New York).


Dr. Lopes made the discovery of A14 in Brazil. He carried out several preliminary studies that support preclinical development. Further preclinical development of A14 will be done in the US.


Patents are owned by the US company. The initial International Patent Application was filed in July 2008, and published in August 2009. A second US Patent Application was filed in March 2012.


We are pleased to work with Cooley LLP for both our intellectual property and corporate legal services.



© NANOCARE 2017               PRIVACY POLICY              LEGAL NOTICE               LEGAL DISCLAIMER               CONTACT US


This site is governed by applicable U.S. laws and governmental regulations. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. To Contact Us or search this site, please see the links on our Home page. All contents © 2013 Nanocare. All rights reserved.